Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898252015> ?p ?o ?g. }
- W2898252015 endingPage "87.e13" @default.
- W2898252015 startingPage "87.e1" @default.
- W2898252015 abstract "BackgroundBecause of the limitations of existing clinical treatments for urinary incontinence, many women with incontinence are interested in complementary strategies for managing their symptoms. Yoga has been recommended as a behavioral self-management strategy for incontinence, but evidence of its feasibility, tolerability, and efficacy is lacking.ObjectiveTo evaluate the feasibility and tolerability of a group-based therapeutic yoga program for ambulatory middle-aged and older women with incontinence, and to examine preliminary changes in incontinence frequency as the primary efficacy outcome after 3 months.Materials and MethodsAmbulatory women aged 50 years or older who reported at least daily stress-, urgency-, or mixed-type incontinence, were not already engaged in yoga, and were willing to temporarily forgo clinical incontinence treatments were recruited into a randomized trial in the San Francisco Bay area. Women were randomly assigned to take part in a program of twice-weekly group classes and once-weekly home practice focused on Iyengar-based yoga techniques selected by an expert yoga panel (yoga group), or a nonspecific muscle stretching and strengthening program designed to provide a rigorous time-and-attention control (control group) for 3 months. All participants also received written, evidence-based information about behavioral incontinence self-management techniques (pelvic floor exercises, bladder training) consistent with usual first-line care. Incontinence frequency and type were assessed by validated voiding diaries. Analysis of covariance models examined within- and between-group changes in incontinence frequency as the primary efficacy outcome over 3 months.ResultsOf the 56 women randomized (28 to yoga, 28 to control), the mean age was 65.4 (±8.1) years (range, 55−83 years), the mean baseline incontinence frequency was 3.5 (±2.0) episodes/d, and 37 women (66%) had urgency-predominant incontinence. A total of 50 women completed their assigned 3-month intervention program (89%), including 27 in the yoga and 23 in the control group (P = .19). Of those, 24 (89%) in the yoga and 20 (87%) in the control group attended at least 80% of group classes. Over 3 months, total incontinence frequency decreased by an average of 76% from baseline in the yoga and 56% in the control group (P = .07 for between-group difference). Stress incontinence frequency also decreased by an average of 61% in the yoga group and 35% in controls (P = .045 for between-group difference), but changes in urgency incontinence frequency did not differ significantly between groups. A total of 48 nonserious adverse events were reported, including 23 in the yoga and 25 in the control group, but none were directly attributable to yoga or control program practice.ConclusionFindings demonstrate the feasibility of recruiting and retaining incontinent women across the aging spectrum into a therapeutic yoga program, and provide preliminary evidence of reduction in total and stress-type incontinence frequency after 3 months of yoga practice. When taught with attention to women’s clinical needs, yoga may offer a potential community-based behavioral self-management strategy for incontinence to enhance clinical treatment, although future research should assess whether yoga offers unique benefits for incontinence above and beyond other physical activity−based interventions. Because of the limitations of existing clinical treatments for urinary incontinence, many women with incontinence are interested in complementary strategies for managing their symptoms. Yoga has been recommended as a behavioral self-management strategy for incontinence, but evidence of its feasibility, tolerability, and efficacy is lacking. To evaluate the feasibility and tolerability of a group-based therapeutic yoga program for ambulatory middle-aged and older women with incontinence, and to examine preliminary changes in incontinence frequency as the primary efficacy outcome after 3 months. Ambulatory women aged 50 years or older who reported at least daily stress-, urgency-, or mixed-type incontinence, were not already engaged in yoga, and were willing to temporarily forgo clinical incontinence treatments were recruited into a randomized trial in the San Francisco Bay area. Women were randomly assigned to take part in a program of twice-weekly group classes and once-weekly home practice focused on Iyengar-based yoga techniques selected by an expert yoga panel (yoga group), or a nonspecific muscle stretching and strengthening program designed to provide a rigorous time-and-attention control (control group) for 3 months. All participants also received written, evidence-based information about behavioral incontinence self-management techniques (pelvic floor exercises, bladder training) consistent with usual first-line care. Incontinence frequency and type were assessed by validated voiding diaries. Analysis of covariance models examined within- and between-group changes in incontinence frequency as the primary efficacy outcome over 3 months. Of the 56 women randomized (28 to yoga, 28 to control), the mean age was 65.4 (±8.1) years (range, 55−83 years), the mean baseline incontinence frequency was 3.5 (±2.0) episodes/d, and 37 women (66%) had urgency-predominant incontinence. A total of 50 women completed their assigned 3-month intervention program (89%), including 27 in the yoga and 23 in the control group (P = .19). Of those, 24 (89%) in the yoga and 20 (87%) in the control group attended at least 80% of group classes. Over 3 months, total incontinence frequency decreased by an average of 76% from baseline in the yoga and 56% in the control group (P = .07 for between-group difference). Stress incontinence frequency also decreased by an average of 61% in the yoga group and 35% in controls (P = .045 for between-group difference), but changes in urgency incontinence frequency did not differ significantly between groups. A total of 48 nonserious adverse events were reported, including 23 in the yoga and 25 in the control group, but none were directly attributable to yoga or control program practice. Findings demonstrate the feasibility of recruiting and retaining incontinent women across the aging spectrum into a therapeutic yoga program, and provide preliminary evidence of reduction in total and stress-type incontinence frequency after 3 months of yoga practice. When taught with attention to women’s clinical needs, yoga may offer a potential community-based behavioral self-management strategy for incontinence to enhance clinical treatment, although future research should assess whether yoga offers unique benefits for incontinence above and beyond other physical activity−based interventions." @default.
- W2898252015 created "2018-11-02" @default.
- W2898252015 creator A5004675496 @default.
- W2898252015 creator A5011079576 @default.
- W2898252015 creator A5019069639 @default.
- W2898252015 creator A5028223973 @default.
- W2898252015 creator A5040530822 @default.
- W2898252015 creator A5042726970 @default.
- W2898252015 creator A5072423985 @default.
- W2898252015 creator A5082809393 @default.
- W2898252015 date "2019-01-01" @default.
- W2898252015 modified "2023-10-16" @default.
- W2898252015 title "A group-based yoga program for urinary incontinence in ambulatory women: feasibility, tolerability, and change in incontinence frequency over 3 months in a single-center randomized trial" @default.
- W2898252015 cites W1227345485 @default.
- W2898252015 cites W1509661225 @default.
- W2898252015 cites W1669177985 @default.
- W2898252015 cites W1943225050 @default.
- W2898252015 cites W1964359719 @default.
- W2898252015 cites W1976357112 @default.
- W2898252015 cites W1977818455 @default.
- W2898252015 cites W1978385754 @default.
- W2898252015 cites W1986955902 @default.
- W2898252015 cites W1987249698 @default.
- W2898252015 cites W1989341824 @default.
- W2898252015 cites W1993384839 @default.
- W2898252015 cites W1995528017 @default.
- W2898252015 cites W2000386797 @default.
- W2898252015 cites W2003679722 @default.
- W2898252015 cites W2005854111 @default.
- W2898252015 cites W2005994117 @default.
- W2898252015 cites W2015130430 @default.
- W2898252015 cites W2020636358 @default.
- W2898252015 cites W2023359850 @default.
- W2898252015 cites W2028950772 @default.
- W2898252015 cites W2040525402 @default.
- W2898252015 cites W2043288 @default.
- W2898252015 cites W2046456635 @default.
- W2898252015 cites W2051068323 @default.
- W2898252015 cites W2053072341 @default.
- W2898252015 cites W2066947273 @default.
- W2898252015 cites W2068329556 @default.
- W2898252015 cites W2074985715 @default.
- W2898252015 cites W2079794617 @default.
- W2898252015 cites W2081691896 @default.
- W2898252015 cites W2082104161 @default.
- W2898252015 cites W2086925513 @default.
- W2898252015 cites W2096505285 @default.
- W2898252015 cites W2104512356 @default.
- W2898252015 cites W2110675017 @default.
- W2898252015 cites W2115469848 @default.
- W2898252015 cites W2115654515 @default.
- W2898252015 cites W2117358263 @default.
- W2898252015 cites W2124448307 @default.
- W2898252015 cites W2124927661 @default.
- W2898252015 cites W2126332162 @default.
- W2898252015 cites W2128269965 @default.
- W2898252015 cites W2128337888 @default.
- W2898252015 cites W2131150360 @default.
- W2898252015 cites W2132832208 @default.
- W2898252015 cites W2134034980 @default.
- W2898252015 cites W2134153020 @default.
- W2898252015 cites W2135372691 @default.
- W2898252015 cites W2135704119 @default.
- W2898252015 cites W2135857642 @default.
- W2898252015 cites W2138266081 @default.
- W2898252015 cites W2142591004 @default.
- W2898252015 cites W2150109369 @default.
- W2898252015 cites W2159997952 @default.
- W2898252015 cites W2164462703 @default.
- W2898252015 cites W2165283552 @default.
- W2898252015 cites W2171795739 @default.
- W2898252015 cites W2316085063 @default.
- W2898252015 cites W2331449654 @default.
- W2898252015 cites W2412636609 @default.
- W2898252015 cites W2529636922 @default.
- W2898252015 doi "https://doi.org/10.1016/j.ajog.2018.10.031" @default.
- W2898252015 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6314206" @default.
- W2898252015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30595143" @default.
- W2898252015 hasPublicationYear "2019" @default.
- W2898252015 type Work @default.
- W2898252015 sameAs 2898252015 @default.
- W2898252015 citedByCount "17" @default.
- W2898252015 countsByYear W28982520152019 @default.
- W2898252015 countsByYear W28982520152020 @default.
- W2898252015 countsByYear W28982520152021 @default.
- W2898252015 countsByYear W28982520152022 @default.
- W2898252015 countsByYear W28982520152023 @default.
- W2898252015 crossrefType "journal-article" @default.
- W2898252015 hasAuthorship W2898252015A5004675496 @default.
- W2898252015 hasAuthorship W2898252015A5011079576 @default.
- W2898252015 hasAuthorship W2898252015A5019069639 @default.
- W2898252015 hasAuthorship W2898252015A5028223973 @default.
- W2898252015 hasAuthorship W2898252015A5040530822 @default.
- W2898252015 hasAuthorship W2898252015A5042726970 @default.
- W2898252015 hasAuthorship W2898252015A5072423985 @default.
- W2898252015 hasAuthorship W2898252015A5082809393 @default.
- W2898252015 hasBestOaLocation W28982520151 @default.
- W2898252015 hasConcept C126322002 @default.